Europe Medical Cannabis Market Share, Size, Growth, Opportunity and Forecast 2021-2026

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Europe Medical Cannabis Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The Europe medical cannabis market is currently witnessing moderate growth. Medical cannabis, or medical marijuana, refers to the plant-derived psychotropic drugs used for the treatment of various medical ailments. It is usually sourced from cannabis indica, sativa and hybrid cannabis plants and the active ingredients include tetrahydrocannabinol (THC) and cannabidiol (CBD). Medical cannabis products are manufactured in the form of oils, capsules and other edible products. They are used for treating chronic pain, anxiety, anorexia, muscle spasms and nausea. Apart from this, they are also effective in modulating the immune system, promoting neuroplasticity and improving vascular and digestive functioning.

The increasing prevalence of chronic medical ailments, such as cancer, arthritis, Alzheimer’s and migraine, is one of the key factors creating a positive outlook for the market. Furthermore, the widespread adoption of medical cannabis for pain management is providing a thrust to the market growth. It is usually inhaled, smoked, orally administered or topically applied to numb the pain receptors and provide instant relief to the patients. Additionally, the legalization of medical cannabis in Europe has enhanced the accessibility of the products through healthcare centers and authorized dispensaries, thereby contributing to the market growth. Other factors, including, extensive research and development (R&D) activities for optimizing the use of cannabinoids, along with improvements in the healthcare infrastructure, are anticipated to drive the market further. Looking forward, IMARC Group expects the market to witness moderate growth during 2021-2026.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the Europe medical cannabis market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, species, derivative, application, end use and route of administration.

Breakup by Species:

Indica
Sativa
Hybrid

Breakup by Derivative:

Cannabidiol (CBD)
Tetrahydrocannabinol (THC)
Others

Breakup by Application:

Cancer
Arthritis
Migraine
Epilepsy
Others

Breakup by End Use:

Pharmaceutical Industry
Research and Development Centres
Others

Breakup by Route of Administration:

Oral Solutions and Capsules
Smoking
Vaporizers
Topicals
Others

Breakup by Country:

Germany
France
United Kingdom
Italy
Spain
Others

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Key Questions Answered in This Report:

How has the Europe medical cannabis market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Europe medical cannabis market?
What are the key regional markets?
What is the breakup of the market based on the species?
What is the breakup of the market based on the derivative?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end use?
What is the breakup of the market based on the route of administration?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the Europe medical cannabis market and who are the key players?
What is the degree of competition in the industry?